未登录Ten-Year Follow-Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT-II): Improved Clinical Outcome After Combination TherapyHepatitis D (HIDIT-II)研究：聚乙二醇干扰素联合替诺福韦治疗96周后的十年随访——联合疗法改善临床结局
Yurdaydin, Cihan; Kahlhofer, Julia; Caruntu, Florin Alexandru; Yalcin, Kendal; Gurel, Selim; Akarca, Ulus S.; Sprinzl, Kathrin; Bock, Hans H.; Bockmann, Jan-hendrik; Papatheodoridis, George V.; Merle, Uta; Demir, Munevver; Hardtke, Svenja; Keskin, Onur; Idilman, Ramazan; Cornberg, Markus; Wedemeyer, Heiner; Wranke, Anika .png)
分享.png)
收藏Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis DAnastasiou, Olympia E.; Caruntu, Florin A.; Curescu, Manuela G.; Yalcin, Kendal; Akarca, Ulus S.; Gurel, Selim; Zeuzem, Stefan; Erhardt, Andreas; Lueth, Stefan; Papatheodoridis, George V.; Keskin, Onur; Port, Kerstin; Radu, Monica; Celen, Mustafa K.; Idilman, Ramazan; Heidrich, Benjamin; Mederacke, Ingmar; von der Leyen, Heiko; Kahlhoefer, Julia; von Karpowitz, Maria; Hardtke, Svenja; Cornberg, Markus; Yurdaydin, Cihan; Wedemeyer, Heiner 分享 收藏 APPLICATION OF NOVEL PACS-BASED INFORMATICS PLATFORM TO IDENTIFY IMAGING BASED PREDICTORS OF CDKN2A ALLELIC STATUS IN GLIOBLASTOMASTillmanns, N. J.; Lost, J.; Tabor, J.; Vasandani, S.; Vetsa, S.; Marianayagam, N.; Yalcin, K.; Erson-Omay, Z.; von Reppert, M.; Jekel, L.; Merkaj, S.; Ramakrishnan, D.; Avesta, A.; Santo, I. Dixe de Oliveira; Jin, L.; Huttner, A.; Bousabarah, K.; Ikuta, I.; Lin, M.; Aneja, S.; Turowski, B.; Aboian, M.; Moliterno, J. 分享 收藏 Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trial丁型肝炎PEG-IFNa-2a治疗96周后生活质量评分改善: hidit-ii试验分析Dinkelborg, Katja; Kahlhoefer, Julia; Doerge, Petra; Yurdaydin, Cihan; Hardtke, Svenja; Caruntu, Florin Alexandru; Curescu, Manuela G.; Yalcin, Kendal; Akarca, Ulus S.; Gurel, Selim; Zeuzem, Stefan; Erhardt, Andreas; Lueth, Stefan; Papatheodoridis, George, V; Keskin, Onur; Port, Kerstin; Radu, Monica; Celen, Mustafa K.; Idilman, Ramazan; Weber, Kristina; Stift, Judith; Wittkop, Ulrike; Heidrich, Benjamin; Mederacke, Ingmar; von der Leyen, Heiko; Dienes, Hans Peter; Cornberg, Markus; Koch, Armin; Manns, Michael P.; Wedemeyer, Heiner; Deterding, Katja 分享 收藏 Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II studyBremer, Birgit; Anastasiou, Olympia E.; Hardtke, Svenja; Caruntu, Florin Alexandru; Curescu, Manuela G.; Yalcin, Kendal; Akarca, Ulus S.; Gurel, Selim; Zeuzem, Stefan; Erhardt, Andreas; Luth, Stefan; Papatheodoridis, George, V; Radu, Monica; Idilman, Ramazan; Manns, Michael P.; Cornberg, Markus; Yurdaydin, Cihan; Wedemeyer, Heiner 分享 收藏 Frequency, severity and impact of Peg-IFNa-associated flares in HDV infection: Results from the HIDIT-II studyHardtke, Svenja; Wedemeyer, Heiner; Caruntu, Florin Alexandru; Curescu, Manuela; Kendal, Yalcin; Akarca, Ulus; Yurdcu, Esra; Gurel, Selim; Zeuzem, Stefan; Erhardt, Andreas; Lueth, Stefan; Papatheodoridis, George; Keskin, Onur; Port, Kerstin; Radu, Monica; Tabak, Fehmi; Idilman, Ramazan; Bozdayi, Mithat; Koch, Armin; Manns, Michael P.; Cornberg, Markus; Yurdaydin, Cihan 分享 收藏 Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trialWedemeyer, Heiner; Yurdaydin, Cihan; Hardtke, Svenja; Caruntu, Florin Alexandru; Curescu, Manuela G.; Yalcin, Kendal; Akarca, Ulus S.; Gurel, Selim; Zeuzem, Stefan; Erhardt, Andreas; Lueth, Stefan; Papatheodoridis, George V.; Keskin, Onur; Port, Kerstin; Radu, Monica; Celen, Mustafa K.; Idilman, Ramazan; Weber, Kristina; Stift, Judith; Wittkop, Ulrike; Heidrich, Benjamin; Mederacke, Ingmar; von der Leyen, Heiko; Dienes, Hans Peter; Cornberg, Markus; Koch, Armin; Manns, Michael P. 分享 收藏 A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 studyWranke, A.; Yurdaydin, C.; Heidrich, B.; Kalliopi, Z.; Yalcin, K.; Fehmi, T.; Akarca, U.; Lammert, F.; Haeussinger, D.; Mueller, T.; Woebse, M.; Manns, M. P.; Wedemeyer, H.; Hardtke, S. 分享 收藏 Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome聚乙二醇干扰素治疗24周时丁型肝炎病毒RNA水平与结果之间的关联Keskin, Onur; Wedemeyer, Heiner; Tuzun, Ali; Zachou, Kalliopi; Deda, Xheni; Dalekos, George N.; Heidrich, Benjamin; Pehlivan, Selcen; Zeuzem, Stefan; Yalcin, Kendal; Gurel, Selim; Tabak, Fehmi; Idilman, Ramazan; Bozkaya, Hakan; Manns, Michael; Yurdaydin, Cihan 分享 收藏 Late HDV RNA Relapse After Peginterferon Alpha-Based Therapy of Chronic Hepatitis Delta基于聚乙二醇干扰素 α 治疗慢性肝炎 δ 后晚期HDV RNA复发Heidrich, Benjamin; Yurdaydin, Cihan; Kabacam, Gokhan; Ratsch, Boris A.; Zachou, Kalliopi; Bremer, Birgit; Dalekos, George N.; Erhardt, Andreas; Tabak, Fehmi; Yalcin, Kendal; Gurel, Selim; Zeuzem, Stefan; Cornberg, Markus; Bock, C. -Thomas; Manns, Michael P.; Wedemeyer, Heiner 分享 收藏 Interleukin-28 gene polymorphisms may contribute to HBsAg persistence and the development of HBeAg-negative chronic hepatitis BKaratayli, Senem C.; Bozdayi, Mithat; Karatayli, Ersin; Ozturk, Tugba; Husseini, Abbas A.; Albayrak, Rabia; Ozkan, Muhip; Kalaylioglu, Zeynep; Yalcin, Kendal; Cinar, Kubilay; Idilman, Ramazan; Yurdaydin, Cihan 分享 收藏 分享 收藏 PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-α-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDV RNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDYWedemeyer, H.; Yurdaydin, C.; Ernst, S.; Caruntu, F. A.; Curescu, M. G.; Yalcin, K.; Akarca, U. S.; Gurel, S.; Zeuzem, S.; Erhardt, A.; Lueth, S.; Papatheodoridis, G. V.; Keskin, O.; Port, K.; Radu, M.; Celen, M. K.; Ildeman, R.; Stift, J.; Heidrich, B.; Mederacke, I.; Hardtke, S.; Koch, A.; Dienes, H. P.; Manns, M. P. 分享 收藏 Role of immunohistochemistry for hepatitis D and hepatitis B virus in hepatitis deltaKabacam, Gokhan; Wedemeyer, Heiner; Savas, Berna; Keskin, Onur; Dalekos, George; Tabak, Fehmi; Idilman, Ramazan; Erhardt, Andreas; Yalcin, Kendal; Bozdayi, Mithat A.; Bozkaya, Hakan; Manns, Michael; Dienes, Hans; Yurdaydin, Cihan 分享 收藏 LONG-TERM FOLLOW-UP AFTER PEG-IFNa2a-BASED THERAPY OF CHRONIC HEPATITIS DELTAHeidrich, B.; Yurdaydin, C.; Kabacam, G.; Zachou, K.; Bremer, B.; Dalekos, G. N.; Erhardt, A.; Cakaloglu, Y.; Yalcin, K.; Gurel, S.; Zeuzem, S.; Bock, T.; Idilman, R.; Manns, M. P.; Wedemeyer, H. 分享 收藏 ANTI-HDV-IgM AS A MARKER OF DISEASE ACTIVITY IN HEPATITIS DELTAWranke, A.; Yurdaydin, C.; Heidrich, B.; Caruntu, F. A.; Curescu, M. G.; Yalcin, K.; Gurel, S.; Zeuzem, S.; Erhardt, A.; Lueth, S.; Papatheodoridis, G. V.; Bremer, B.; Stift, J.; Grabowski, J.; Kirschner, J.; Port, K.; Cornberg, M.; Falk, C.; Dienes, H. P.; Hardtke, S.; Manns, M. P.; Wedemeyer, H. 分享 收藏 分享 收藏 ANTI-HDV-IGM TESTING IN HEPATITIS DELTA REVISITED: CORRELATIONS WITH DISEASE ACTIVITY AND RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENTMederacke, I.; Yurdaydin, C.; Bremer, B.; Cakaloglu, Y.; Erhardt, A.; Yalcin, K.; Zachou, K.; Guerel, S.; Heidrich, B.; Dalekos, G.; Dienes, H. P.; Manns, M. P.; Wedemeyer, H. 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
